Medical/Pharmaceuticals
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis
NEWTON, Mass. and FLORENCE, Italy, Nov. 1, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, today anno...
Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration
SUNNYVALE, Calif., Nov. 1, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy system for the Type B market has been submitted to the Chinese National Medical Products Administration (N...
Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company
With more than 1,600 employees across the globe, the new organization is now one of the world's largest pharma intelligence solutions providers on the market YARDLEY, Pa., Nov. 1, 2022 /PRNewswire/ -- Norstella, a global leader with end-to-end solutions that smooth access to life-saving therapies...
Pervistop®, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide.
Lo.Li. Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners. Pervistop® promises to be an extremely effective tool in the management of an exceedingly unpredictable disease. FRANKFURT, Germany, Nov. 1,...
Gerresheimer AG and Stevanato Group present EZ-fill Smart™, a new and innovative Ready-To-Fill Vial Platform
DÜSSELDORF, Germany and PIOMBINO DESE, Italy, Nov. 1, 2022 /PRNewswire/ -- Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics and Stevanato Group S.p.A., a global provider of drug containment, drug delivery and diagnostic ...
RemeGen Releases Phase II Clinical Study Data for Treatment of Myasthenia Gravis in Chinese Patients
YANTAI, China, Nov.1, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, recently released data from the Phase II clinical study of its proprietary novel fusion protein Telitacicept for the treatment of myasthenia ...
GenScript Supported Nasal Spray Development for COVID-19 Protection with GMP-grade Antibodies and Subsequently Planned for Long-Term Collaboration with Biogenexis
SINGAPORE, Nov. 1, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supportedChulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production a...
Codex Genetics to Offer Guardant Health's Precision Oncology Tests in Hong Kong and Macau
HONG KONG, Nov. 1, 2022 /PRNewswire/ -- Codex Genetics today announced an exclusive collaboration with Guardant Health Asia,Middle East and Africa (AMEA) to offer comprehensive genomic profiling (CGP) tests to hospitals and clinics in Hong Kong and Macau. As part of the collaboration, Gua...
Antengene Receives U.S. FDA Clearance of IND Application for Phase I Trial of Small Molecule ERK1/2 Inhibitor ATG-017 in Patients with Advanced Solid Tumors
* ATG-017 is a small molecule ERK1/2 inhibitor and Antengene has obtained exclusive global rights to develop, commercialize and manufacture ATG-017. * IND clearance enables Antengene to initiate the combination portion of the Phase I "ERASER" clinical trial inthe United States (U.S.) to evalua...
EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine
PROVIDENCE, R.I., Oct. 31, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will be...
Xinhua Silk Road: Cloud + offline fair injects new vitality into National TCM Materials & Pharmaceuticals Trade Fair
BEIJING, Oct. 31, 2022 /PRNewswire/ -- The 53rd National Traditional Chinese Medicine (TCM) Materials and Pharmaceuticals Trade Fair, a vital platform to promote communication in medical field inChina, bore witness to how online-offline integration greatly boosted trading on the opening day on Fr...
BRONCUS'S DISPOSABLE NEBULIZING MICRO-CATHETER FOR ENDOSCOPE WAS APPROVED FOR MARKETING IN CHINA AND ITS APPLICATIONS IN DRUG-DEVICE COMBINATION WILL BE BROADENED
HANGZHOU, China, Oct. 31, 2022 /PRNewswire/ -- Broncus is pleased to announce that onOctober 28, 2022, the Company's innovative product in the field of drug-device combination, "Mist FountainTM" (the "Product" or "Nebulizing Micro-Catheter"), a disposable nebulizing micro-catheter for endoscope, ...
Bowtie partners with Take2 and SCOR to develop an innovative cancer screening solution, sponsor over 1,000 high-risk customers to conduct early nasopharyngeal cancer detection test
85% of nasopharyngeal cancer patients are from Asia. Early detection increases
survival rate by nearly 30%
HONG KONG, Oct. 31, 2022 /PRNewswire/ -- Bowtie
Intellect partners with Tinder to support mental well-being amongst young adult singles in Southeast Asia
SINGAPORE, Oct. 31, 2022 /PRNewswire/ -- In light of Mental Health Awareness
Month,Intellect
Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 (Recombinant anti-Claudin18.2 Monoclonal Antibody-drug Conjugate) in Patients with Advanced Solid Tumors
ROCKVILLE, Md. and SUZHOU, China, Oct. 30, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmolog...
Samyang Holdings' Lafullen Makes Splash in Korean Medical Aesthetics Market
- Successfully demonstrated Lafullen's safety and efficacy at autumn medical symposiums - Shared treatment protocols and clinical cases to lecturers by specialist - Continued to develop evidence-based marketing to Asian markets SEOUL, South Korea, Oct. 31, 2022 /PRNewswire/ -- Samyang Holdings ...
Unload Psoriatic Disease: World Psoriasis Day 2022
STOCKHOLM, Oct. 29, 2022 /PRNewswire/ -- World Psoriasis Day is October 29th.
Each year, the global psoriatic disease community unites for action to raise
awareness of psoriatic disease. This year's theme is mental health.
World Stroke Organization Tackle Gaps in Access to Quality Stroke Care
GENEVA, Switzerland, Oct. 28, 2022 /PRNewswire/ -- On World Stroke Day (29th
Oct), the World Stroke Organization has announced the launch of a new program
that aims to drive access to quality acute stroke care and save lives around
the world.
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit
BOSTON, Oct. 29, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc. (STAR: 688302), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, today presented their preclinical results of ...
GORE COMPLETES FIRST IN-HUMAN IMPLANTS OF THE GORE® VIAFORT VASCULAR STENT
CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease. FLAGSTAFF, Ariz., Oct. 29, 2022 /PRNewswire/ -- W. L. Gore & Associat...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Multiple achievements made in China-Hungary BRI conference
[Picked up by 317 media titles]
2024-05-03 06:59Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 287 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21